Biontech

Latest Stories

People walk by an electronic stock board of a securities firm in Tokyo, Tuesday, Nov. 10, 2020. Asian stock markets rose for second day Tuesday on hopes for progress toward a possible coronavirus vaccine that might allow the world to revive manufacturing, shopping and normal life. (AP Photo/Koji Sasahara)

Asian shares mostly higher as focus shifts to virus recovery

By ELAINE KURTENBACH - Associated Press

A general view of Pfizer Manufacturing Belgium in Puurs, Belgium, Monday, Nov. 9, 2020. Pfizer said Monday that early results from its coronavirus vaccine suggest the shots may be a surprisingly robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration in the United States. (AP Photo/Virginia Mayo)

EU to buy up to 300 million doses of Pfizer-BioNTech vaccine

Associated Press

An ad for COVID-19 testing reflects on glass at a bus stop, as pedestrians walk past Pfizer world headquarters in New York on Monday Nov. 9, 2020. Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, but it doesn't mean a vaccine is imminent. (AP Photo/Bebeto Matthews)

Key events in development of Pfizer’s COVID-19 vaccine

By AP Medical Writer - Associated Press

Pedestrians walk past Pfizer world headquarters in New York on Monday Nov. 9, 2020. Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, but it doesn't mean a vaccine is imminent. (AP Photo/Bebeto Matthews)

Testing timeline: What’s ahead for COVID-19 vaccines

By LAURAN NEERGAARD - Associated Press

In this photo provided by Cincinnati Children’s Hospital Medical Center, clinical research coordinator Tammy Lewis-McCauley administers an injection to Katelyn Evans, a trial participant, as part of the hospital’s clinical trial of Pfizer's COVID-19 vaccine at Cincinnati Children’s Hospital Medical Center on Wednesday, Oct. 14, 2020. (Cincinnati Children’s Hospital Medical Center via AP)

Pfizer: Early look shows COVID-19 vaccine is 90% effective

By Tom Howell Jr. - The Washington Times

In this photo provided by Cincinnati Children’s Hospital Medical Center, clinical research coordinator Tammy Lewis-McCauley administers an injection to Katelyn Evans, a trial participant, as part of the hospital’s clinical trial of Pfizer's COVID-19 vaccine at Cincinnati Children’s Hospital Medical Center on Wednesday, Oct. 14, 2020. (Cincinnati Children’s Hospital Medical Center via AP)

Pfizer says early data signals COVID-19 vaccine is effective

By Linda A. Johnson and Lauran Neergaard - Associated Press

A man walks past an electronic stock board showing Japan's Nikkei 225 index at a securities firm in Tokyo Monday, Nov. 9, 2020. Asian shares rose Monday on relief the U.S. presidential election results were finally decided, with Joe Biden the president-elect. (AP Photo/Eugene Hoshiko)

Asian stocks rise for 2nd day on coronavirus vaccine hopes

By JOE McDONALD - Associated Press

FILE - In this Feb. 26, 2019 file photo, Albert Bourla, chief executive officer of Pfizer, prepares to testify before the Senate Finance Committee hearing on drug prices, on Capitol Hill in Washington. Pfizer Inc.'s CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes well. The announcement on Friday, Oct. 16, 2020, by Bourla reflects estimates from leading scientists that its unlikely data would start to emerge until November or December showing any of the leading vaccine candidates work. (AP Photo/Pablo Martinez Monsivais, File)

Pfizer: Mid-November earliest it can seek virus vaccine OK

Associated Press

German Health Minister Jens Spahn, left, and Science and Education Minister Anja Karliczek, right, arrive for a news conference about a german program to support the develop a COVID-19 vaccine in Berlin, Germany, Tuesday, Sept. 15, 2020.(AP Photo/Markus Schreiber, Pool)

Germany boosts own vaccine makers in race for COVID-19 jab

Associated Press

Scientific Games; Nvidia rise; Marathon Oil, Hologic fall

Associated Press

Navajo Nation will participate in COVID-19 vaccine trials

Associated Press

In this Jan. 24, 2018, file photo, Albert Bourla, of Pfizer, attends the 48th annual meeting of the World Economic Forum, WEF, in Davos, Switzerland. (Gian Ehrenzeller/Keystone via AP, File)

Pfizer CEO:Albert Bourla: ‘Best guess’ is we’ll know efficacy of vaccine by end of October

By David Sherfinski - The Washington Times

A man stands near an electronic stock board showing Japan's Nikkei 225 index at a securities firm as a car passes by in Tokyo Thursday, Aug. 20, 2020. Asian shares slipped Thursday after sobriety set in on Wall Street, and the U.S. Federal Reserve minutes laid out challenges for the economy amid the coronavirus pandemic. (AP Photo/Eugene Hoshiko)

Asian shares track Wall Street gains amid vaccine hopes

By YURI KAGEYAMA - Associated Press

An inmate models the protective gear inmates manufacture as fellow inmate Luis Huaman makes face shields at a workshop in the Lurigancho prison, on the outskirts of Lima, Peru, Wednesday, Aug. 19, 2020. Health authorities and inmates look to implement protocols to curb the spread of COVID-19 at the overcrowded prison. (AP Photo/Martin Mejia)

The Latest: Virus spike in S Korea capital may be spreading

By The Associated Press - Associated Press

Connecticut Gov. Ned Lamont speaks at a press conference at Pfizer Groton on the companies research to develop a vaccine for COVID-19, Wednesday, July 22, 2020, in Groton, Conn. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Stew Milne)

Pandemic hurts sales, profit for Pfizer amid restructuring

By LINDA A. JOHNSON - Associated Press

A woman wearing a face mask stands beneath a bank's electronic board showing the Hong Kong share index at Hong Kong Stock Exchange in Hong Kong Tuesday, July 28, 2020. Shares advanced in Asia on Tuesday after U.S. stocks resumed their upward march on Wall Street, while the price of gold pushed to nearly $1,970 per ounce. (AP Photo/Vincent Yu)

Asian shares mixed amid dismal earnings, Wall Street slump

By YURI KAGEYAMA - Associated Press

FILE - In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday, July 1, 2020. (University of Maryland School of Medicine via AP)

Feds agree to buy 100 M doses of potential Pfizer vaccine

By The Associated Press - Associated Press

President Donald Trump speaks during a news conference at the White House, Wednesday, July 22, 2020, in Washington. (AP Photo/Evan Vucci)

Pfizer coronavirus vaccine deal touted by Trump

By Tom Howell Jr. - The Washington Times

Best Buy, Silgan rise; Snap, FirstEnergy fall

Associated Press

John Burkhardt, left, senior vice president of drug safety R&amp;D and head of the Pfizer Groton site speaks at a press conference at Pfizer Groton on the companies research to develop a vaccine for COVID-19, as Connecticut Gov. Ned Lamont stands by to answer questions Wednesday, July 22, 2020, in Groton, Conn. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Stew Milne)

Pfizer’s CT scientists playing key role in vaccine effort

By SUSAN HAIGH - Associated Press